GRI Bio, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 1.89 million compared to USD 2.15 million a year ago. Basic loss per share from continuing operations was USD 0.46.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4007 USD | -1.18% | +2.72% | -85.13% |
- Stock Market
- Equities
- GRI Stock
- News GRI Bio, Inc.
- GRI Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024